BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Adeline Bertola. Rodent models of fatty liver diseasesLiver Research 2018; 2(1): 3 doi: 10.1016/j.livres.2018.03.001
2
Kikumi Ono-Moore, Matthew Ferguson, Michael Blackburn, Hassan Issafras, Sean Adams. Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in MiceNutrients 2016; 9(1): 16 doi: 10.3390/nu9010016
3
Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne S. Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 369 doi: 10.1007/978-3-030-11748-1_14
4
Takuma Tsuchida, Youngmin A. Lee, Naoto Fujiwara, Maria Ybanez, Brittany Allen, Sebastiao Martins, M. Isabel Fiel, Nicolas Goossens, Hsin-I. Chou, Yujin Hoshida, Scott L. Friedman. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancerJournal of Hepatology 2018; 69(2): 385 doi: 10.1016/j.jhep.2018.03.011
5
Peter Lykke Eriksen, Hendrik Vilstrup, Kristoffer Rigbolt, Malte P. Suppli, Michael Sørensen, Sara Heebøll, Sanne S. Veidal, Fillip K. Knop, Karen Louise Thomsen. Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversionLiver International 2019; 39(11): 2094 doi: 10.1111/liv.14205
6
Henrik H. Hansen, Michael Feigh, Sanne S. Veidal, Kristoffer T. Rigbolt, Niels Vrang, Keld Fosgerau. Mouse models of nonalcoholic steatohepatitis in preclinical drug developmentDrug Discovery Today 2017; 22(11): 1707 doi: 10.1016/j.drudis.2017.06.007
7
Jonathan D Roth, Michael Feigh, Sanne S Veidal, Louise KD Fensholdt, Kristoffer T Rigbolt, Henrik H Hansen, Li C Chen, Mathieu Petitjean, Weslyn Friley, Niels Vrang, Jacob Jelsing, Mark Young. INT-767 improves histopathological features in a diet-induced <i>ob/ob</i> mouse model of biopsy-confirmed non-alcoholic steatohepatitisWorld Journal of Gastroenterology 2018; 24(2): 195-210 doi: 10.3748/wjg.v24.i2.195
8
Amandine Everard, Hubert Plovier, Marialetizia Rastelli, Matthias Van Hul, Alice de Wouters d’Oplinter, Lucie Geurts, Céline Druart, Sylvie Robine, Nathalie M. Delzenne, Giulio G. Muccioli, Willem M. de Vos, Serge Luquet, Nicolas Flamand, Vincenzo Di Marzo, Patrice D. Cani. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosisNature Communications 2019; 10(1) doi: 10.1038/s41467-018-08051-7
9
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat sourceWorld Journal of Gastroenterology 2019; 25(33): 4904-4920 doi: 10.3748/wjg.v25.i33.4904
10
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, Michael Feigh, Niels Vrang, Jonathan David Roth, Mary Erickson, Luciano Adorini, Jacob Jelsing. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASHBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1149-z
11
Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, Francois Pattou, Bart Staels, Michael Wagner. Incretin combination therapy for the treatment of non‐alcoholic steatohepatitisDiabetes, Obesity and Metabolism 2020; 22(8): 1328 doi: 10.1111/dom.14035
12
Kandy T Velázquez, Reilly T Enos, Jackie E Bader, Alexander T Sougiannis, Meredith S Carson, Ioulia Chatzistamou, James A Carson, Prakash S Nagarkatti, Mitzi Nagarkatti, E Angela Murphy. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in miceWorld Journal of Hepatology 2019; 11(8): 619-637 doi: 10.4254/wjh.v11.i8.619
13
Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza Potes. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver DiseaseNutrients 2019; 11(12): 2871 doi: 10.3390/nu11122871
14
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, Marc Foretz, Patrick C. Even, Dalila Azzout‐Marniche, Andreas Nygaard Madsen, Martin Illemann, Karen Mandrup, Michael Feigh, Jörg Czech, Heiner Glombik, Jacob A. Olsen, Wolfgang Hennerici, Klaus Steinmeyer, Ralf Elvert, Tamara R. Castañeda, Aimo Kannt. Activation of Adenosine Monophosphate—Activated Protein Kinase Reduces the Onset of Diet‐Induced Hepatocellular Carcinoma in MiceHepatology Communications 2020; 4(7): 1056 doi: 10.1002/hep4.1508
15
Helmut Denk, Peter M. Abuja, Kurt Zatloukal. Animal models of NAFLD from the pathologist's point of viewBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 929 doi: 10.1016/j.bbadis.2018.04.024
16
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2019; 64(5): 1238 doi: 10.1007/s10620-018-5395-7
17
Michelle L. Boland, Rhianna C. Laker, Karly Mather, Arkadiusz Nawrocki, Stephanie Oldham, Brandon B. Boland, Hilary Lewis, James Conway, Jacqueline Naylor, Silvia Guionaud, Michael Feigh, Sanne S. Veidal, Louise Lantier, Owen P. McGuinness, Joseph Grimsby, Cristina M. Rondinone, Lutz Jermutus, Martin R. Larsen, James L. Trevaskis, Christopher J. Rhodes. Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesisNature Metabolism 2020; 2(5): 413 doi: 10.1038/s42255-020-0209-6
18
Bader Zarrouki, Jeremie Boucher. Kupffer CellsMethods in Molecular Biology 2020; 2164: 121 doi: 10.1007/978-1-0716-0704-6_13
19
Manuel Baader, Tom Bretschneider, Andre Broermann, Joerg F Rippmann, Birgit Stierstorfer, Christian A Kuttruff, Michael Mark. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosisBritish Journal of Pharmacology 2018; 175(4): 693 doi: 10.1111/bph.14118
20
Daniel Jahn, Stefan Kircher, Heike M. Hermanns, Andreas Geier. Animal models of NAFLD from a hepatologist's point of viewBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 943 doi: 10.1016/j.bbadis.2018.06.023
21
Malte P. Suppli, Kristoffer T. G. Rigbolt, Sanne S. Veidal, Sara Heebøll, Peter Lykke Eriksen, Mia Demant, Jonatan I. Bagger, Jens Christian Nielsen, Denise Oró, Sebastian W. Thrane, Asger Lund, Charlotte Strandberg, Merete J. Kønig, Tina Vilsbøll, Niels Vrang, Karen L. Thomsen, Henning Grønbæk, Jacob Jelsing, Henrik H. Hansen, Filip K. Knop. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individualsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 316(4): G462 doi: 10.1152/ajpgi.00358.2018
22
Naomichi Abe, Sayuka Kato, Takuma Tsuchida, Kanami Sugimoto, Ryuta Saito, Lars Verschuren, Robert Kleemann, Kozo Oka. Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patientsBiology Open 2019; 8(5): bio041251 doi: 10.1242/bio.041251
23
David H Ipsen, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?Advances in Nutrition 2020;  doi: 10.1093/advances/nmaa081
24
Xiaobo Wang, Mark R. Sommerfeld, Kerstin Jahn‐Hofmann, Bishuang Cai, Aveline Filliol, Helen E. Remotti, Robert F. Schwabe, Aimo Kannt, Ira Tabas. A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in MiceHepatology Communications 2019; 3(9): 1221 doi: 10.1002/hep4.1405
25
Michelle L Boland, Stephanie Oldham, Brandon B Boland, Sarah Will, Jean-Martin Lapointe, Silvia Guionaud, Christopher J Rhodes, James L Trevaskis. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunctionWorld Journal of Gastroenterology 2018; 24(16): 1748-1765 doi: 10.3748/wjg.v24.i16.1748
26
Diego Almanza, Mehrnaz Gharaee-Kermani, Alisa Zhilin-Roth, Jose A. Rodriguez-Nieves, Cory Colaneri, Todd Riley, Jill A. Macoska. Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular SignatureDigestive Diseases and Sciences 2019; 64(5): 1257 doi: 10.1007/s10620-018-5398-4
27
João Pedroso, João Camporez, Luciana Belpiede, Rafaela Pinto, José Cipolla-Neto, Jose Donato. Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic ResonanceDiagnostics 2019; 9(4): 198 doi: 10.3390/diagnostics9040198
28
Jamie Bates, Archana Vijayakumar, Sarani Ghoshal, Bruno Marchand, Saili Yi, Dmytro Kornyeyev, Anna Zagorska, David Hollenback, Katie Walker, Kathy Liu, Swetha Pendem, David Newstrom, Robert Brockett, Igor Mikaelian, Saritha Kusam, Ricardo Ramirez, David Lopez, Li Li, Bryan C. Fuchs, David G. Breckenridge. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activationJournal of Hepatology 2020;  doi: 10.1016/j.jhep.2020.04.037
29
Aimo Kannt, Efstathia Papada, Claire Kammermeier, Giuseppe D'Auria, Nuria Jiménez‐Hernández, Martin Stephan, Uwe Schwahn, Andreas Nygaard Madsen, Mette Viberg Østergaard, George Dedoussis, M. Pilar Francino. Mastiha ( Pistacia lentiscus ) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis Molecular Nutrition & Food Research 2019; 63(24): 1900927 doi: 10.1002/mnfr.201900927
30
Victoria S. Jensen, Pernille Tveden-Nyborg, Christina Zacho-Rasmussen, Michelle L. Quaade, David H. Ipsen, Henning Hvid, Christian Fledelius, Erik M. Wulff, Jens Lykkesfeldt. Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent modelsJournal of Pharmacological and Toxicological Methods 2020; 101: 106651 doi: 10.1016/j.vascn.2019.106651
31
Jonathan D. Roth, Sanne S. Veidal, Louise K. D. Fensholdt, Kristoffer T. G. Rigbolt, Romeo Papazyan, Jens Christian Nielsen, Michael Feigh, Niels Vrang, Mark Young, Jacob Jelsing, Luciano Adorini, Henrik H. Hansen. Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASHScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45178-z
32
Helene M. Ægidius, Sanne S. Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte R. Kornum, Blagoy Blagoev, Kristoffer T. G. Rigbolt. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58059-7
33
Mikhaïl Van Herck, Luisa Vonghia, Sven Francque. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s GuideNutrients 2017; 9(10): 1072 doi: 10.3390/nu9101072
34
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in miceBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
35
Adeline Bertola. WITHDRAWN: Rodent models of fatty liver diseasesLiver Research 2018;  doi: 10.1016/j.livres.2018.02.005
36
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing, Kristoffer T. G. Rigbolt. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01356-2
37
Daniel Veyel, Kathrin Wenger, Andre Broermann, Tom Bretschneider, Andreas H. Luippold, Bartlomiej Krawczyk, Wolfgang Rist, Eric Simon. Biomarker discovery for chronic liver diseases by multi-omics – a preclinical case studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58030-6
38
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
39
Kirstine S Tølbøl, Maria NB Kristiansen, Henrik H Hansen, Sanne S Veidal, Kristoffer TG Rigbolt, Matthew P Gillum, Jacob Jelsing, Niels Vrang, Michael Feigh. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitisWorld Journal of Gastroenterology 2018; 24(2): 179-194 doi: 10.3748/wjg.v24.i2.179
40
Oren Tirosh. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease ProgressionOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/2548154
41
F. Anthony Romero, Christopher T. Jones, Yingzi Xu, Martijn Fenaux, Randall L. Halcomb. The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver DiseaseJournal of Medicinal Chemistry 2020; 63(10): 5031 doi: 10.1021/acs.jmedchem.9b01701
42
Yeon Ji Chae, Dae Won Jun, Waqar Khalid Saeed, Hyeon Tae Kang, Ju Hee Oh, Seung Min Lee, Kiseok Jang. Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver StudiesJournal of Korean Medical Science 2019; 34(2) doi: 10.3346/jkms.2019.34.e14
43
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructoseBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4